Rabbit Anti-REL Recombinant Antibody (clone R03-3D5) (CAT#: VS3-FY1988)
The anti-c-Rel antibody detected in western blot analysis of c-Rel in Hela, A549, HL-60 lysates. This product is a extraordinary rabbit recombinant monoclonal antibody that is designed to compete for binding to human REL. It is suitable for use in a variety of assays, including WB, IP.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 Anti-REL Antibody (VS3-FY1988) in WB.
The c-Rel expression in Hela, A549, HL-60 lysates were detected using the anti-c-Rel by western blot assay.
Specifications
- Immunogen
- Synthetic peptide of human c-Rel
- Host Species
- Rabbit
- Type
- Rabbit IgG
- Specificity
- Human REL
- Species Reactivity
- Human
- Clone
- R03-3D5
- Applications
- Western Blot, Immunoprecipitation
- MW
- The calculated weight of the target protein is approximately 69 kDa, while the observed molecular weight stands at 78 kDa.
- Related Disease
- Immunodeficiency 92 and Reticuloendotheliosis
Product Property
- Purification
- Affinity Purified
- Format
- Liquid
- Concentration
- Please refer to the vial label for the specific concentration.
- Buffer
- 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% glycerol, 0.05% BSA
- Preservative
- 0.01% Sodium azide
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- Western Blot: 1/500-1/1000
Immunoprecipitation: 1/20
Target
- Alternative Names
- REL Proto-Oncogene, NF-KB Subunit; V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog; Oncogene REL, Avian Reticuloendotheliosis; Proto-Oncogene C-Rel; C-Rel
- Gene ID
- 5966
- UniProt ID
- Q04864
- Cellular Localization
- Nucleus
- Post Translation Modifications
- Modification sites at PhosphoSitePlus (Q04864)
Modification sites at neXtProt (NX_Q04864)
Glycosylation from GlyGen (Q04864) 8 sites, 2 O-linked glycans (8 sites)
- Protein Refseq
- XP_011531312.1; XP_016860116.1; XP_054199242.1; XP_054199243.1; NP_001278675.1
- Function
- Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis.
Recommended Products
Isotype Control
Secondary Antibody
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "REL"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-3042 | Hi-Affi™ Recombinant Rabbit Anti-REL Monoclonal Antibody (DS3042AB) | ICC, IHC-P, IP, WB | IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS3-FY1988. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: ELISA
Application: ELISA, IHC, FC, WB, IF, IA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, Inhib, FuncS
Application: ELISA, FC, IHC, Neut
Application: ELISA, Inhib, FC, Neut
Application: Neut, ELISA, IF, IP, FuncS, FC
Application: ELISA
Application: Inhib, FC, WB
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.